Evidence map›Paper›PMID 40559732›Full record

ArticleTropical medicine and infectious disease2025

Emergence of Multidrug-Resistant

Tajana Juzbašić, Nataša Andrijašević, Ivana Ferenčak, Dragan Jurić, Silvija Šoprek, Vlatka Poje Janeš, Ljiljana Žmak, Arjana Tambić Andrašević, Ana Gverić Grginić

Abstract readCase Reports
In one paragraph

Article in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Tropical medicine and infectious disease · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tajana JuzbašićDepartment of Microbiology, Croatian Institute of Public Health, 10000 Zagreb, Croatia.ORCID 0009-0007-1937-7181
Nataša AndrijaševićDepartment for Clinical Microbiology, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.
Ivana FerenčakDepartment of Microbiology, Croatian Institute of Public Health, 10000 Zagreb, Croatia.ORCID 0000-0002-9285-9052
Dragan JurićDepartment of Microbiology, Croatian Institute of Public Health, 10000 Zagreb, Croatia.ORCID 0009-0000-6564-1616
Silvija ŠoprekDepartment for Clinical Microbiology, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.ORCID 0000-0002-5413-8393
Vlatka Poje JanešDepartment for Microbiology, Public Health Institute of Koprivnica Križevci County, 48000 Koprivnica, Croatia.
Ljiljana ŽmakDepartment of Microbiology, Croatian Institute of Public Health, 10000 Zagreb, Croatia.ORCID 0000-0002-8354-3945
Arjana Tambić AndraševićDepartment for Clinical Microbiology, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.ORCID 0000-0001-6232-1465
Ana Gverić GrginićDepartment of Microbiology, Croatian Institute of Public Health, 10000 Zagreb, Croatia.

Funding

European Union's Health and Digital Executive Agency (HaDEA) No 101102440.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Campylobacter jejuniCVIDimmunocompromised patientsmultidrug resistancerecurrent infectionwhole genome sequencing

Identifiers

PMID40559732
PMCPMC12197775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.